Frontiers Association of Lipoprotein(a)-Associated Mortality and

Por um escritor misterioso
Last updated 25 abril 2025
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Cover Story Emerging From the Shadows: Lp(a) - American College of Cardiology
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Genome-Wide Association Study and Identification of a Protective Missense Variant on Lipoprotein(a) Concentration
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
IJERPH, Free Full-Text
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study, Thrombosis Journal
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Biomedicines, Free Full-Text

© 2014-2025 trend-media.tv. All rights reserved.